Medical News Today (press release) - Jan 24, 2010
The investigation, comparing the effect of treatment of COPD exacerbations with moxifloxacin (400 mg/day for five days) and amoxicillin/clavulanate (500/125 ...
Dieser Bakterientyp kann Resistenzen gegen bestimmte Antibiotika wie Methicillin, Oxacillin, Penicillin und Amoxicillin bilden. Der Antikörper KBSA301 hat ...